Schedule 13D ownership disclosure

Mirati Therapeutics Inc

Security class unavailable · CUSIP: 60468T105

Event date: 2020-10-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
4.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-20-282990
Form type
SC 13D/A
Filer
Boxer Capital, LLC
CIK
CIK 1465837
Filed
Nov 02, 2020
Reporting period
Oct 28, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub